RecruitingNot ApplicableNCT07027891

The Rule-Out Acute Myocardial Infarction Using Aritifical Intelligence Electrocardiogram (ROMIAE) 2 Trial

ROMIAE 2 Trial: Randomized Controlled Trial for Managing Suspicious Acute Myocardial Infarction in ED Using AI-ECG

Sponsor

CHA University

Enrollment

4,670 participants

Start Date

Jul 1, 2025

Study Type

INTERVENTIONAL

Conditions

Myocardial Infarction (MI)Chest Pain Rule Out Myocardial Infarction

Summary

This study is to see whether the AI ECG assisted protocol is as safe and efficacious as conventional protocol in early triage of suspected myocardial infarction.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called AI-ECG for people with chest pain rule out myocardial infarction and myocardial infarction (mi). The study is currently recruiting participants at 12 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEAI-ECG

The patients in AI-ECG group would be managed with the information of the myocardial infarction risk score in AI-ECG in addition to the usual care.

Locations(12)

Asan Medical Center

Seoul, South Korea

CHA Bundang Medical Center

Seoul, South Korea

Ewha Womans University

Seoul, South Korea

Gangnam Severance Hospital

Seoul, South Korea

Hanyang University

Seoul, South Korea

Jeonbuk National University Hospital

Seoul, South Korea

Korea University Ansan Hospital

Seoul, South Korea

Korea University Guro Hospital

Seoul, South Korea

Kyung Hee University Hospital

Seoul, South Korea

Samsung Medical Center

Seoul, South Korea

Soonchunhyang University Bucheon Hospital

Seoul, South Korea

Yonsei University Wonju College of Medicine

Seoul, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07027891

Related Trials

Diagnostic Accuracy of GPT-4o and Claude for HEART Score Calculation in Chest Pain

NCT076260601 location

BEAT-SHOCK Registry

NCT076436101 location

Low-dose Interleukin-2 After Myocardial Infarction to Investigate Effects on Tissue-resident Regulatory T Cells

NCT076105382 locations

Ticino Artificial InTelligence integrAtioN for Occlusion Myocardial Infarction

NCT070770571 location

GSI Cardiac on Revolution Apex - US

NCT067029171 location